@article{56ac09826caf4e2d910a30556ebf07cd,
title = "Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?",
author = "Heinz Wiendl and Dennis Bourdette and Olga Ciccarelli",
note = "Funding Information: H.W.{\textquoteright}s work is supported by the German Research Foundation (DFG) and the Ministry of Education and Research (BMBF, the German Competence Network MK, KKNMS). D.B. receives research funding from the U.S. National MS Society. O.C. receives funding from UK MS Society and Rosetree Trust and her work is supported by NIHR UCLH BRC.",
year = "2017",
month = sep,
day = "1",
doi = "10.1212/WNL.0000000000004381",
language = "English (US)",
volume = "89",
pages = "1098--1100",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",
}